Gut Microbiota in Non-Alcoholic Fatty Liver Disease Patients with Inflammatory Bowel Diseases: A Complex Interplay

被引：25

作者：

Abenavoli, Ludovico ^{[1
]}

Giubilei, Lidia ^{[1
]}

Procopio, Anna Caterina ^{[1
]}

Spagnuolo, Rocco ^{[1
]}

Luzza, Francesco ^{[1
]}

Boccuto, Luigi ^{[2
]}

Scarpellini, Emidio ^{[3
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy

[2] Clemson Univ, Sch Nursing, Clemson, SC 29634 USA

[3] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Gasthuisberg Univ Hosp, Herestr 49, B-3000 Leuven, Belgium

来源：

NUTRIENTS | 2022年 / 14卷 / 24期

关键词：

microbiota; non-alcoholic fatty liver disease; Crohn's disease; ulcerative colitis; EXPRESSION; ABUNDANCE; DYSBIOSIS;

D O I：

10.3390/nu14245323

中图分类号：

R15 [营养卫生、食品卫生]; TS201 [基础科学];

学科分类号：

100403 ;

摘要：

The intestinal microbiota represents the microbial community that colonizes the gastrointestinal tract and constitutes the most complex ecosystem present in nature. The main intestinal microbial phyla are Firmicutes, Bacteroidetes, Actinobacteria, Proteobacteria, Fusobacteria, and Verrucromicrobia, with a clear predominance of the two phyla Firmicutes and Bacteroidetes which account for about 90% of the intestinal phyla. Intestinal microbiota alteration, or dysbiosis, has been proven to be involved in the development of various syndromes, such as non-alcoholic fatty liver disease, Crohn's disease, and ulcerative colitis. The present review underlines the most recurrent changes in the intestinal microbiota of patients with NAFLD, Crohn's disease, and ulcerative colitis.

引用

页数：10

共 50 条

[21] Inpatient Outcomes in Inflammatory Bowel Disease Patients With Non-Alcoholic Fatty Liver Disease
Patel, Nisha
Pusateri, Antoinette J.
Hinton, Alice
Afzali, Anita
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S396 - S396
[22] Risk Factors of Non-alcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease
Sourianarayanane, Achuthan
Garg, Gaurav
Smith, Thomas
Butt, Mujtaba
McCullough, Arthur
Shen, Bo
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S155 - S155
[23] EVALUATION OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Cohen, Mallory
Khanna, Geetika
Deepak, Parakkal
Samson, Charles
GASTROENTEROLOGY, 2020, 158 (06) : S973 - S974
[24] Targeting the Gut Microbiota for the Treatment of Non-Alcoholic Fatty Liver Disease
Mouzaki, Marialena
Bandsma, Robert
CURRENT DRUG TARGETS, 2015, 16 (12) : 1324 - 1331
[25] Non-alcoholic fatty liver disease and the gut microbiota in adolescents: is there a relationship?
El Amrousy, Doaa
El Ashry, Heba
Maher, Sara
Elsayed, Yousef
Hasan, Samir
BMC PEDIATRICS, 2024, 24 (01)
[26] Gut microbiota and non-alcoholic fatty liver disease: new insights
Aron-Wisnewsky, J.
Gaborit, B.
Dutour, A.
Clement, K.
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (04) : 338 - 348
[27] Microbiota and non-alcoholic fatty liver disease
Link, A.
Thon, C.
Sydor, S.
Canbay, A.
GASTROENTEROLOGE, 2019, 14 (03): : 179 - 184
[28] Mechanisms behind the Role of SIBO in Non-Alcoholic Fatty Liver Disease: An Interplay between Liver, Gut Microbiota and Nutrition
Yigit, Asli
Samur, Gulhan
CURRENT NUTRITION & FOOD SCIENCE, 2023, 19 (02) : 84 - 93
[29] THE PATHOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASE CORRELATES WITH GUT MICROBIOTA COMPOSITION IN MICE: FROM NON-ALCOHOLIC FATTY LIVER TO NON-ALCOHOLIC STEATOHEPATITIS
Peng, J.
Huang, F.
Li, X.
Chen, L.
Feng, Q.
Hu, Y.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S155 - S157
[30] Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling Pathways
Kang, Limin
Ma, Xiaolong
Yu, Fakun
Xu, Lei
Lang, Li
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2024, 34 (12) : 2637 - 2647

← 1 2 3 4 5 →